To evaluate the extent to which dysregulated LRP1–PDGFR-β signaling predisposes to AngII-induced aneurysm, we sought to rescue the exacerbated phenotype of Tβ4–/Y mice by pharmacological inhibition of the pathway. This evidence concerns the gene AGT and aneurysm.